| Part Of FDA Holds an Open Meeting on the Pfizer-BioNTech COVID-19 Vaccine

FDA Meeting on COVID-19 Vaccine and Emergency Use Authorization, Part 1

The Food and Drug Administration hosted a virtual open meeting to discuss Pfizer-BioNTech COVID-19 vaccine and Emergency Use Authorization (EUA).… read more

The Food and Drug Administration hosted a virtual open meeting to discuss Pfizer-BioNTech COVID-19 vaccine and Emergency Use Authorization (EUA). Members of the Vaccines and Related Biological Products Advisory Committee (VRBPA) heard testimony regarding issues related to Pfizer’s vaccine including its safety and effectiveness, distribution, and ethical considerations for ongoing vaccine trials. close

Report Video Issue

Points of Interest

For quick viewing, C-SPAN provides Points of Interest markers for some events.

Click the play button and tap the screen to see the at the bottom of the player. Tap the to see a complete list of all Points of Interest - click on any moment in the list and the video will play.

Points of Interest

For quick viewing, C-SPAN provides Points of Interest markers for some events.

Click the play button and move your cursor over the video to see the . Click on the marker to see the description and watch.

You can also click the in the lower left of the video player to see a complete list of all Points of Interest from this program - click on any moment in the list and the video will play.

People in this video

  • Paula Annunziato Associate Vice President Merck Research Laboratories
  • Prabhakara Atreya Director U.S. Food and Drug Administration->Scientific Advisers and Consultants
  • Juan Banacloche Specialist Mayo Clinic->Infectious Diseases
  • Archana Chatterjee Senior Associate Dean University of South Dakota->Medical School
  • Amanda Cohn Executive Secretary Advisory Committee on Immunization Practices
  • Doran Fink Deputy Director U.S. Food and Drug Administration->Vaccines and Related Biological Products Advisory Committee
  • Oveta Fuller Professor University of Michigan Medical School
  • Hayley Gans Professor Stanford University->Pediatric Infectious Diseases
  • Steven Goodman Professor Stanford University->Epidemiology and Health
  • Marion Gruber Director U.S. Food and Drug Administration->Office of Vaccine Research and Review
  • Aron Hall Co-Lead Centers for Disease Control and Prevention->Epidemiology Task Force
  • James Hildreth M.D. President and CEO Meharry Medical College
  • Mike Kaczynski Project Manager U.S. Food and Drug Administration
  • David Kim Director Centers for Disease Control and Prevention->Immunization Division
  • Michael Kurilla Director National Institutes of Health->Division of Clinical Innovation
  • Jeannette Lee Professor University of Arkansas->Biostatistics
  • Ofer Levy Director Boston Children's Hospital->Precision Vaccines Program
  • Peter W. Marks M.D. Director U.S. Food and Drug Administration->Center for Biologics Evaluation and Research
  • Pamela McInnes Director National Institutes of Health->National Center for Advancing Translational Sciences
  • Cody Meissner Professor Tufts University->Infectious Diseases
  • Nancy Messonnier Director Centers for Disease Control and Prevention->National Center for Immunization and Respiratory Diseases
  • Arnold Monto Professor University of Michigan->Epidemiology
  • Patrick Moore Professor University of Pittsburgh->Cancer Institute
  • Paul Offit M.D. Director Children's Hospital of Philadelphia->Vaccination Education Center
  • Anita Patel Deputy Centers for Disease Control and Prevention->Vaccine Task Force
  • Steven Pergam Professor Fred Hutchinson Cancer Research Center
  • Stanley Perlman M.D. Professor University of Iowa->Immunology
  • Eric Rubin Editor in Chief New England Journal of Medicine
  • Mark Sawyer M.D. Specialist Rady Children's Hospital->Infectious Diseases
  • Sheldon Toubman Assistant Attorney New Haven Legal Assistance
  • Ralph Tripp Associate Professor University of Georgia->Veterinary Infectious Diseases
  • Melinda Wharton Director Centers for Disease Control and Prevention->Immunization Division
More People

Hosting Organization

More Videos From

FDA Holds an Open Meeting on the Pfizer-BioNTech COVID-19 Vaccine

More information about

FDA Meeting on COVID-19 Vaccine and Emergency Use Authorization, Part 1

6,101 Views
Category:
Public Affairs Event
Format:
Meeting
Location:
Washington, District of Columbia, United States
First Aired:
Dec 10, 2020 | 8:59am EST | C-SPAN 3
Last Aired:
Dec 13, 2020 | 1:14pm EST | C-SPAN 1

Airing Details

  • Dec 10, 2020 | 8:59am EST | C-SPAN 3
  • Dec 10, 2020 | 11:38am EST | C-SPAN 3
  • Dec 10, 2020 | 8:01pm EST | C-SPAN 1
  • Dec 13, 2020 | 1:14pm EST | C-SPAN 1

User Created Clips from This Video